162 related articles for article (PubMed ID: 11378539)
1. Therapy related leukemias: susceptibility, prevention and treatment.
Leone G; Voso MT; Sica S; Morosetti R; Pagano L
Leuk Lymphoma; 2001 Apr; 41(3-4):255-76. PubMed ID: 11378539
[TBL] [Abstract][Full Text] [Related]
2. The incidence of secondary leukemias.
Leone G; Mele L; Pulsoni A; Equitani F; Pagano L
Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043
[TBL] [Abstract][Full Text] [Related]
3. Secondary leukemias induced by topoisomerase-targeted drugs.
Felix CA
Biochim Biophys Acta; 1998 Oct; 1400(1-3):233-55. PubMed ID: 9748598
[TBL] [Abstract][Full Text] [Related]
4. [Leukemias induced by anticancer chemotherapies].
Harousseau JL
Bull Cancer; 1999 Nov; 86(11):929-38. PubMed ID: 10586109
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy of secondary leukemias.
Visani G; Pagano L; Pulsoni A; Tosi P; Piccaluga PP; Pastano R; Grafone T; Malagola M; Isidori A; Tura S
Leuk Lymphoma; 2000 May; 37(5-6):543-9. PubMed ID: 11042514
[TBL] [Abstract][Full Text] [Related]
6. [Chromosome translocations and leukemias induced by inhibitors of topoisomerase II anticarcinogenic drugs].
Dassonneville L; Bailly C
Bull Cancer; 1998 Mar; 85(3):254-61. PubMed ID: 9752316
[TBL] [Abstract][Full Text] [Related]
7. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risks.
Smith MA; Rubinstein L; Ungerleider RS
Med Pediatr Oncol; 1994; 23(2):86-98. PubMed ID: 8202047
[TBL] [Abstract][Full Text] [Related]
8. Incidence and susceptibility to therapy-related myeloid neoplasms.
Leone G; Fianchi L; Pagano L; Voso MT
Chem Biol Interact; 2010 Mar; 184(1-2):39-45. PubMed ID: 20026017
[TBL] [Abstract][Full Text] [Related]
9. Secondary myelodysplastic syndromes and acute leukemias.
Zeidman A; Dayan DB; Mittelman M
Haematologia (Budap); 1995; 27(1):23-8. PubMed ID: 12051292
[TBL] [Abstract][Full Text] [Related]
10. Therapy-related leukemia and myelodysplasia: susceptibility and incidence.
Leone G; Pagano L; Ben-Yehuda D; Voso MT
Haematologica; 2007 Oct; 92(10):1389-98. PubMed ID: 17768113
[TBL] [Abstract][Full Text] [Related]
11. Secondary acute myeloid leukemia in children previously treated with alkylating agents, intercalating topoisomerase II inhibitors, and irradiation.
Sandoval C; Pui CH; Bowman LC; Heaton D; Hurwitz CA; Raimondi SC; Behm FG; Head DR
J Clin Oncol; 1993 Jun; 11(6):1039-45. PubMed ID: 8388919
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplasias and leukemias after autologous stem cell transplantation for lymphoid malignancies.
Park S; Brice P; Noguerra ME; Simon D; Rousselot P; Kerneis Y; Morel P; Marolleau JP; Gisselbrecht C
Bone Marrow Transplant; 2000 Aug; 26(3):321-6. PubMed ID: 10967573
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetic characteristics of 115 consecutive cases and risk in seven cohorts of patients treated intensively for malignant diseases in the Copenhagen series.
Pedersen-Bjergaard J; Philip P; Larsen SO; Andersson M; Daugaard G; Ersbøll J; Hansen SW; Hou-Jensen K; Nielsen D; Sigsgaard TC
Leukemia; 1993 Dec; 7(12):1975-86. PubMed ID: 8255096
[TBL] [Abstract][Full Text] [Related]
14. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
15. Genetic abnormalities in leukemia secondary to treatment in patients with Hodgkin's disease.
Salas C; Pérez-Vera P; Frías S
Rev Invest Clin; 2011; 63(1):53-63. PubMed ID: 21574543
[TBL] [Abstract][Full Text] [Related]
16. [Therapy-related hematologic neoplasias after breast cancer. Epidemiologic, etiologic and cytogenetic aspects and new risk factors according to published data and own results].
Haase D; Hanf V; Schulz T
Med Klin (Munich); 2004 Sep; 99(9):506-17. PubMed ID: 15372180
[TBL] [Abstract][Full Text] [Related]
17. Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations.
Thirman MJ; Gill HJ; Burnett RC; Mbangkollo D; McCabe NR; Kobayashi H; Ziemin-van der Poel S; Kaneko Y; Morgan R; Sandberg AA
N Engl J Med; 1993 Sep; 329(13):909-14. PubMed ID: 8361504
[TBL] [Abstract][Full Text] [Related]
18. Biology and therapy of secondary leukaemias.
Dann EJ; Rowe JM
Best Pract Res Clin Haematol; 2001 Mar; 14(1):119-37. PubMed ID: 11355927
[TBL] [Abstract][Full Text] [Related]
19. Therapy-related myeloid leukaemia: a model for leukemogenesis in humans.
Larson RA; Le Beau MM
Chem Biol Interact; 2005 May; 153-154():187-95. PubMed ID: 15935816
[TBL] [Abstract][Full Text] [Related]
20. Myeloid leukemia after hematotoxins.
Larson RA; LeBeau MM; Vardiman JW; Rowley JD
Environ Health Perspect; 1996 Dec; 104 Suppl 6(Suppl 6):1303-7. PubMed ID: 9118910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
